We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $786B
1-Year Est. Return 40.34%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-8.3%
1 Year Est. Return
+40.34%
3 Year Est. Return
+112.81%
5 Year Est. Return
+128.34%
10 Year Est. Return
+415.77%
AUM
$141B
AUM Growth
-$9.21B
Cap. Flow
+$2.66B
Cap. Flow %
1.88%
Top 10 Hldgs %
17.26%
Holding
9,177
New
665
Increased
3,304
Reduced
3,723
Closed
707

Sector Composition

Rank Sector Weight
1 Miscellaneous 50.44%
2 Financials 8.35%
3 Energy 6.57%
4 Healthcare 6.43%
5 Technology 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PED icon
7776
PEDEVCO
PED
$189M
$4K ﹤0.01%
84
+29
+53% +$1.99K
PLUR icon
7777
Pluri
PLUR
$13.8M
$4K ﹤0.01%
24
+11
+85% +$1.91K
PLX icon
7778
Protalix BioTherapeutics
PLX
$218M
$4K ﹤0.01%
369
+289
+361% +$4.59K
PULM icon
7779
Pulmatrix
PULM
$5.11M
$4K ﹤0.01%
4
-6
-60% -$7.55K
SMLR
7780
DELISTED
Semler Scientific
SMLR
$4K ﹤0.01%
1,653
+494
+43% +$1.52K
SNFCA icon
7781
Security National Financial
SNFCA
$226M
$4K ﹤0.01%
1,140
-13,867
-92% -$57.1K
STAA icon
7782
STAAR Surgical
STAA
$1.09B
$4K ﹤0.01%
510
-403
-44% -$3.32K
TARA icon
7783
Protara Therapeutics
TARA
$217M
$4K ﹤0.01%
7
-7
-50% -$4.33K
THC icon
7784
CALL
Tenet Healthcare
THC
$21B
$4K ﹤0.01%
100
-100
-50% -$5.17K
TXT icon
7785
CALL
Textron
TXT
$14B
$4K ﹤0.01%
100
-100
-50% -$4.14K
TXT icon
7786
PUT
Textron
TXT
$14B
$4K ﹤0.01%
100
VUZI icon
7787
Vuzix
VUZI
$227M
$4K ﹤0.01%
954
-1,507
-61% -$7.71K
XELB icon
7788
Xcel Brands
XELB
$6.03M
$4K ﹤0.01%
+50
New +$4.37K
XLU icon
7789
CALL
State Street Utilities Select Sector SPDR ETF
XLU
$21.6B
$4K ﹤0.01%
200
-1,349,000
-100% -$29M
XOMA
7790
CALL
DELISTED
Xoma
XOMA
$4K ﹤0.01%
245
ZEUS
7791
DELISTED
Olympic Steel
ZEUS
$4K ﹤0.01%
406
+44
+12% +$557
ZTS icon
7792
CALL
Zoetis
ZTS
$29.9B
$4K ﹤0.01%
100
-100
-50% -$4.64K
CSCI
7793
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$4K ﹤0.01%
+5
New +$7.28K
FLG
7794
PUT
Flagstar Bank National Association
FLG
$5.29B
$4K ﹤0.01%
67
GRCE
7795
Grace Therapeutics
GRCE
$45.2M
$4K ﹤0.01%
33
-2
-6% -$335
VBFC
7796
DELISTED
Village Bank and Trust Financial Corp.
VBFC
$4K ﹤0.01%
189
-291
-61% -$5.82K
ENSV
7797
DELISTED
Enservco Corp.
ENSV
$4K ﹤0.01%
402
+322
+403% +$4.99K
SEEL
7798
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
BIMI
7799
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
$4K ﹤0.01%
71
+43
+154% +$2.7K
ESHY
7800
DELISTED
Xtrackers J.P. Morgan ESG USD High Yield Corporate Bond ETF
ESHY
$4K ﹤0.01%
+188
New +$4.4K

Similar funds

UBS Group's Q3 2015 Portfolio in Review

As of Q3 2015, UBS Group held 9,177 positions worth $141B, down 6.1% from $150B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

UBS Group's Q3 2015 filing shows 665 new, 3,304 increased, 3,723 reduced and 707 closed positions. Its largest new stake was The Kraft Heinz Company: 1,448,913 shares worth $102M. The largest sale was Apple, an estimated $399M.

By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, up from 47% a quarter earlier, followed by Financials and Energy.

  • UBS Group's largest Q3 2015 buy was The Kraft Heinz Company: 1,448,913 shares worth $102M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2015, an estimated $2.97B increase.
  • UBS Group's biggest Q3 2015 reduction was Apple, cutting an estimated $399M.
  • UBS Group fully exited OMNICARE INC in Q3 2015, selling an estimated $227M.
  • UBS Group's ten largest holdings make up 17% of its $141B portfolio in Q3 2015.
  • UBS Group opened 665 new positions and closed 707 in Q3 2015.
  • UBS Group's portfolio value fell 6.1% quarter-over-quarter to $141B.

Based on UBS Group's 13F filing for Q3 2015, filed 13 Nov 2015.